NF‐κB activation and subsequent SASP induction have been observed in some type of drug‐induced cancer cell senescence (DIS) treated by certain antitumor agents and notably contribute to patient outcome after cancer chemotherapy by stimulating immune system to eliminate senescent cancer cells. The gene discussed is NFKB1; the disease is cancer.